| RS1588743576 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1588757756 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS1588770875 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1588784791 |
EHMT1
|
Health Risk |
Pathogenic |
Marfanoid habitus and intellectual disability, Kleefstra syndrome 1 |
| RS1588810676 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1588810695 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1588811810 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS1588816777 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1588830568 |
INPP5E
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Rod-cone dystrophy |
| RS1588833694 |
SLC44A1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1588844639 |
SLC34A3
|
Health Risk |
Likely pathogenic |
Hypercalciuria, Hypercalciuria |
| RS1588848475 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588854011 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1588855714 |
SYNE1
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1588862565 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588862595 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS1588862638 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS1588862691 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588863938 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588864028 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1588864039 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1588864152 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1588865728 |
RBP3
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1588866040 |
RET
|
Health Risk |
Pathogenic |
Hirschsprung disease, susceptibility to |
| RS1588869546 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588871361 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588871393 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588872865 |
RET
|
Health Risk |
Likely pathogenic |
Aganglionic megacolon, Aganglionic megacolon |
| RS1588873476 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1588874068 |
RET
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1588874416 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588875719 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1588876500 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588881831 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1588893751 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Histiocytic medullary reticulosis |
| RS1588896721 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
— |
| RS1588927571 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1D |
| RS1588973202 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Spinal muscular atrophy-progressive myoclonic epilepsy syndrome |
| RS1588973237 |
ASAH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588973247 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588974098 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588974267 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588974593 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588977010 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588977181 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588978684 |
ASAH1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, Farber lipogranulomatosis |
| RS1588978706 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588978873 |
ASAH1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, Farber lipogranulomatosis |
| RS1588980220 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1588982399 |
ASAH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588982421 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588986195 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588989947 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588989964 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588990194 |
ASAH1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, Spinal muscular atrophy-progressive myoclonic epilepsy syndrome |
| RS1588999312 |
ASAH1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, Spinal muscular atrophy-progressive myoclonic epilepsy syndrome |
| RS1588999386 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1588999402 |
ASAH1
|
Health Risk |
Likely pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1589036783 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1589040836 |
GLE1
|
Health Risk |
Pathogenic |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS1589050343 |
DCLRE1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS1589052989 |
DNAJC12
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia due to DNAJC12 deficiency, Hyperphenylalaninemia due to DNAJC12 deficiency |
| RS1589058964 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1589059043 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Adams-Oliver syndrome 5 |
| RS1589063073 |
NOTCH1
|
Health Risk |
Pathogenic |
NOTCH1-related disorder, NOTCH1-related disorder |
| RS1589064285 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1589064324 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1589066272 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS1589070600 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1589072024 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1589072933 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS1589079163 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS1589080524 |
EGR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1589080604 |
EGR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1589080611 |
EGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1D, Charcot-Marie-Tooth disease type 1D |
| RS1589088690 |
WDR37
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurooculocardiogenitourinary syndrome, 6 conditions |
| RS1589088702 |
WDR37
|
Health Risk |
Likely pathogenic |
Neurooculocardiogenitourinary syndrome, 6 conditions |
| RS1589088703 |
WDR37
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurooculocardiogenitourinary syndrome, 6 conditions |
| RS1589093778 |
CACNA1B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements |
| RS1589095160 |
CACNA1B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements |
| RS1589110050 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS1589111139 |
JMJD1C
|
Health Risk |
Likely pathogenic |
— |
| RS1589112601 |
CACNA1B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements |
| RS1589115392 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS1589115549 |
WAC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1589136659 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS1589149178 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1589150410 |
FAM149B1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 36, Joubert syndrome |
| RS1589150589 |
JMJD1C
|
Health Risk |
Pathogenic |
— |
| RS1589152355 |
NODAL
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1589152470 |
NODAL
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1589156388 |
PCDH15
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1F |
| RS1589170008 |
JMJD1C
|
Health Risk |
Likely pathogenic |
— |
| RS1589196229 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1589196234 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS1589219377 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1589220231 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS1589229634 |
WHRN
|
Health Risk |
Pathogenic |
Usher syndrome type 2D, Usher syndrome |
| RS1589232076 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1589233357 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis |